EFTA00677967.pdf
dataset_9 pdf 139.7 KB • Feb 3, 2026 • 3 pages
From: Richard Merkin •cl
To: Jeffrey Epstein -4
Subject: Re: Following up on our conversation in LA
Date: Sun, 19 May 2013 15:03:37 +0000
Not to the northeast for awhile
On May 19, 2013, at 7:00 AM, "Jeffrey Epstein" c > wrote:
are you planning on east coast soon?
On Thu, May 16, 2013 at 4:23 PM, Richard Merkin < > wrote:
We're scheduled to talk on June 3rd
From: Jeffrey Epstein [mailto:
Sent: Thursday, May 16, 2013 7:46 AM
To: Richard Merkin
Subject: Re: Following up on our conversation in LA
where is the article?
On Thu, May 16, 2013 at 9:46 AM, Richard Merkin l> wrote:
We called and spoke to Meghan last week . will call again this am.You know I follow up.ps article today about Oregon
and stem cells Are you aware ?
From: Jeffrey Epstein [mailto:
Sent: Thursday, May 16, 2013 3:56 AM
To: Richard Merkin
Subject: Fwd: Following up on our conversation in LA
Forwarded message
From: george church
Date: Thursday, May 16, 2013
Subject: Following u on our conversation in LA
To: Jeffrey Epstein
EFTA00677967
Jeffrey,
Thanks again for your intro.
No response, so far, from Richard Merkin.
--geo
From: george church <
Date: Sunday, May 5, 2013 9:30 AM
To: Richard Merkin
Cc: Jeffrey Epstein < Meghan Radden >
Subject: Following up on our conversation in LA
Thanks for the introduction. I believe that you both were interested in our disruptive technologies (precise, fast and
inexpensive) for human genome (and microbiome) engineering -- especially in the context of our PGP biobank human stem
cell samples — which we (& NIST + FDA genomeinabottle.org) feel are the only ones in the world properly consented for
broad commercial use. be delighted to discuss this and other projects (e.g. the BRAIN Innovative Neurotech Project that
we recently initiated) in more detail — if like, Meghan (M) can help with scheduling, etc.
-- Geo
All appointments via
From: Jeffrey Epstein
Date: Wednesday, May 1, 2013 4:48 PM
To: george church Richard Merkin < >
george dick, dick george.
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
EFTA00677968
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00677969
Entities
0 total entities mentioned
No entities found in this document
Document Metadata
- Document ID
- 4c89fc7d-822c-40b8-9b45-357c90ff336f
- Storage Key
- dataset_9/EFTA00677967.pdf
- Content Hash
- 01b34edd6d009cd7f533feeb8af75478
- Created
- Feb 3, 2026